Skip to main content
. 2022 Dec;81(12):328–332.

Table 2.

Frequency of Administration of Medications by Anesthesia Providers during Dilation and Evacuation in Patients who Received Oxytocin or Placebo

Medication Number of Patients Who
Received Medication
N
Placebo
N (%)a
Oxytocin
N (%)
P-value
Acetaminophen 15 12 (80) 3 (20) .02
Cisatracurium 2 1 (50) 1 (50) <.99
Desflurane 5 3 (60) 2 (40) .65
Dexamethasone 54 27 (50) 27 (50) <.99
Famotidine 1 0 (0) 1 (100) .32
Fentanyl 104 50 (48) 54 (52) .14
Isoflurane 5 4 (80) 1 (20) .17
Lidocaine 25 13 (52) 12 (48) .82
Metoclopramide 11 3 (27) 8 (73) .11
Midazolam 46 19 (41) 27 (59) .18
Nitrous oxide 17 8 (47) 9 (53) .79
Ondansetron 82 42 (51) 40 (49) .67
Phenylephrine 2 2 (100) 0 (0) .15
Promethazine 1 1 (100) 0 (0) .32
Propofol 105 53 (50) 52 (50) .70
Rocuronium 18 7 (39) 11 (61) .30
Sevoflurane 91 43 (47) 48 (53) .23
Succinylcholine 54 27 (50) 27 (50) <.99
a

N represents the number of participants who received the medication in the placebo or oxytocin groups; % represents the frequency of those who received the medication by group.